PENTASA Side Effects

5529823-2 | Dyspepsia, Flatulence, Nasal Congestion, Sinus Headache
on Nov 12, 2007 Female patient from UNITED STATES , 54 years of age, weighting 104.9 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: dyspepsia, flatulence, nasal congestion, sinus headache. Pentasa dosage: See Image. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ).

5523264-X | Interstitial Lung Disease
Patient was taking Pentasa (View Usage). Patient had the following side effects: interstitial lung disease on Nov 02, 2007 from JAPAN Additional patient health information: Female patient , 75 years of age, was diagnosed with colitis ulcerative and. Pentasa dosage: 750 Mg, 3x/day:tid, Oral. During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

5520430-4 | Gastric Ulcer, Post Procedural Haemorrhage
Adverse event was reported on Oct 31, 2007 by a Male patient taking Pentasa (View Usage) (Dosage: 4x/day:qid, Oral; 500 Mg, 4x/4day:qid, Oral) was diagnosed with colitis ulcerative and. Location: UNITED STATES , 83 years of age, weighting 134.9 lb, After Pentasa was administered, patient had the following side effects: gastric ulcer, post procedural haemorrhage. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

5505516-2 | Interstitial Lung Disease
on Oct 16, 2007 Female patient from JAPAN , 70 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Pentasa dosage: Oral. Patient was hospitalized.


5500113-7 | International Normalised Ratio Increased
on Oct 10, 2007 Male patient from UNITED KINGDOM , 73 years of age, was treated with Pentasa (View Usage). Patient had the following side effects: international normalised ratio increased. Pentasa dosage: 500 Mg, Oral. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

5500110-1 | Interstitial Lung Disease, Lung Disorder, Pleural Disorder, Vomiting
Patient was taking Pentasa (View Usage). After Pentasa was administered, patient had the following side effects: interstitial lung disease, lung disorder, pleural disorder (What is pleural disorder?), vomiting on Oct 09, 2007 from DENMARK Additional patient health information: Male patient , 26 years of age, was diagnosed with colitis ulcerative and. Pentasa dosage: 2 G Daily, Oral; 3 G Daily, Oral.

5488873-5 | Myositis
Adverse event was reported on Oct 01, 2007 by a Male patient taking Pentasa (View Usage) (Dosage: 1000 Mg, 3x/day:tid, Oral) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: JAPAN , 36 years of age, Patient experienced the following unwanted or unexpected effects: myositis (What is myositis?). Patient was hospitalized.

5484811-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Amylase Increased, Blood Lactate Dehydrogenase Increased, C-reactive Protein Increased, Disseminated Intravascular Coagulation, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal
on Sep 26, 2007 Male patient from SWEDEN , 17 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood amylase increased, blood lactate dehydrogenase increased, c-reactive protein increased, disseminated intravascular coagulation, gamma-glutamyltransferase increased, hepatic function abnormal. Pentasa dosage: 750 Mg, 3x/day:tid, Oral; 500 Mg, 3x/day:tid, Oral; 750 Mg, 3x/day:tid, Oral. During the same period patient was treated with CEFDINIR (View Cefdinir Review and Cefdinir Label ), CEFAZOLIN /00010902/ (CEFALOTIN SODIUM) (View Cefazolin /00010902/ (cefalotin Sodium) Review and Cefazolin /00010902/ (cefalotin Sodium) Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), PREDNISONE ACETATE (PREDNISONE ACETATE) (View Prednisone Acetate (prednisone Acetate) Review and Prednisone Acetate (prednisone Acetate) Label ), AMPICILLIN SODIUM W/SULBACTRAM SODIUM (AMPICILLIN SODIUM, SULBACTAM SO (View Ampicillin Sodium W/sulbactram Sodium (ampicillin Sodium, Sulbactam So Review and Ampicillin Sodium W/sulbactram Sodium (ampicillin Sodium, Sulbactam So Label ). Patient was hospitalized.

5468209-6 | Blood Lactate Dehydrogenase Increased, Blood Sodium Decreased, Central Line Infection, Cryptogenic Organising Pneumonia, Diffuse Alveolar Damage, Enterococcal Infection, Iatrogenic Injury, Pneumothorax, Polyneuropathy
on Sep 07, 2007 Male patient from DENMARK , 71 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). After Pentasa was administered, patient had the following side effects: blood lactate dehydrogenase increased, blood sodium decreased, central line infection, cryptogenic organising pneumonia, diffuse alveolar damage, enterococcal infection, iatrogenic injury, pneumothorax, polyneuropathy. Pentasa dosage: 3 G, Daily, Oral. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), SERETIDE /0142090/ (FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE) (View Seretide /0142090/ (fluticasone Propionate, Salmeterol Xinafoate) Review and Seretide /0142090/ (fluticasone Propionate, Salmeterol Xinafoate) Label ). Patient was hospitalized.

5468208-4 | Asthma
Patient was taking Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?) on Sep 07, 2007 from DENMARK Additional patient health information: Female patient , 34 years of age, . Pentasa dosage: 3g Daily, Oral.

5452202-3 | Chemical Injury, Colitis, Diarrhoea Haemorrhagic, Duodenitis, Gastritis, Haematemesis, Hypersensitivity, Ileitis
Adverse event was reported on Sep 05, 2007 by a Male patient taking Pentasa (View Usage) (Dosage: 1 G, 4x/day; Qid, Oral) was diagnosed with colitis ulcerative and. Location: UNITED STATES , 21 years of age, Patient had the following side effects: chemical injury, colitis, diarrhoea haemorrhagic, duodenitis, gastritis, haematemesis, hypersensitivity, ileitis. During the same period patient was treated with PREDNISONE (CORTICOSTEROID NOS) (View Prednisone (corticosteroid Nos) Review and Prednisone (corticosteroid Nos) Label ). Patient was hospitalized.

5451852-8 | Cryptogenic Organising Pneumonia, Diffuse Alveolar Damage, Fibrosis, Pneumothorax, Polyneuropathy, Vomiting
on Aug 28, 2007 Male patient from DENMARK , 71 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). After Pentasa was administered, patient had the following side effects: cryptogenic organising pneumonia, diffuse alveolar damage, fibrosis, pneumothorax, polyneuropathy, vomiting. Pentasa dosage: 3 G, Daily, Oral. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), SERETIDE(FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE) (View Seretide(fluticasone Propionate, Salmeterol Xinafoate) Review and Seretide(fluticasone Propionate, Salmeterol Xinafoate) Label ). Patient was hospitalized.

5451850-4 | Insomnia, Stomatitis, Swollen Tongue
on Aug 29, 2007 Female patient from DENMARK , 25 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: insomnia, stomatitis, swollen tongue. Pentasa dosage: 500 Mg, 2x/day:bid, Oral : 750 G, 3x/day:tid, Oral : 2250 Mg Daily, Oral.

5448244-4 | Abdominal Pain, Arthralgia, Chills, Diarrhoea, Headache, Liver Disorder, Pyrexia
Patient was taking Pentasa (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), arthralgia, chills, diarrhoea, headache (What is headache?), liver disorder, pyrexia on Aug 23, 2007 from JAPAN Additional patient health information: Female patient , 38 years of age, was diagnosed with colitis ulcerative and. Pentasa dosage: 750 Mg, 3x/day:tid, Oral. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NIZATIDINE (View Nizatidine Review and Nizatidine Label ), CALCITRIOL (View Calcitriol Review and Calcitriol Label ). Patient was hospitalized.

5441597-2 | Myositis
Adverse event was reported on Aug 14, 2007 by a Male patient taking Pentasa (View Usage) (Dosage: 3 G Daily, Oral) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: JAPAN , 36 years of age, After Pentasa was administered, patient had the following side effects: myositis (What is myositis?). Patient was hospitalized.

5431294-1 | Crohn's Disease, Dyspepsia, Flatulence, Sinus Headache
on Aug 23, 2007 Female patient from UNITED STATES , 55 years of age, weighting 104.9 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: crohn's disease (What is crohn's disease?), dyspepsia, flatulence, sinus headache. Pentasa dosage: See Image. During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), NIACIN (View Niacin Review and Niacin Label ).

5430302-1 | Abdominal Pain, Arthralgia, Chills, Diarrhoea, Headache, Nausea, Pyrexia
on Aug 14, 2007 Female patient from JAPAN , 38 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), arthralgia, chills, diarrhoea, headache (What is headache?), nausea (What is nausea?), pyrexia. Pentasa dosage: 750 Mg, 3x/day; Tid, Oral. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NIZATIDINE (View Nizatidine Review and Nizatidine Label ), CALCITRIOL (View Calcitriol Review and Calcitriol Label ). Patient was hospitalized.

5424289-5 | Diarrhoea, Haemodialysis, Nephritis Interstitial, Rectal Haemorrhage, Renal Failure Acute, Renal Tubular Necrosis
Patient was taking Pentasa (View Usage). After Pentasa was administered, patient had the following side effects: diarrhoea, haemodialysis, nephritis interstitial, rectal haemorrhage, renal failure acute, renal tubular necrosis on Aug 06, 2007 from JAPAN Additional patient health information: Male patient , 21 years of age, was diagnosed with colitis ulcerative and. Pentasa dosage: 750 Mg, 3x/day:tid, Oral, 1000 Mg, 1x/day:qd, Rectal. During the same period patient was treated with FERROUS SODIUM CITRATE (FERROUS SODIUM CITRATE) (View Ferrous Sodium Citrate (ferrous Sodium Citrate) Review and Ferrous Sodium Citrate (ferrous Sodium Citrate) Label ). Patient was hospitalized.

5416437-8 | Cellulitis, Leukopenia, Perianal Abscess, Sepsis
Adverse event was reported on Jul 31, 2007 by a Male patient taking Pentasa (View Usage) (Dosage: 2 G Daily, Oral) was diagnosed with colitis ulcerative and. Location: NETHERLANDS , 67 years of age, Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?), leukopenia, perianal abscess, sepsis (What is sepsis?). During the same period patient was treated with ACENOCOUMAROL (ACENOCOUMAROL) (View Acenocoumarol (acenocoumarol) Review and Acenocoumarol (acenocoumarol) Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

5416436-6 | Cardiac Failure, Lung Infiltration, Oedema Peripheral, Pleural Effusion, Pneumonitis
on Jul 30, 2007 Female patient from JAPAN , 70 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). Patient had the following side effects: cardiac failure, lung infiltration, oedema peripheral, pleural effusion, pneumonitis. Pentasa dosage: 750 Mg, 3x/day; Tid; Oral. During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ETIZOLAM (ETIZOLAM) (View Etizolam (etizolam) Review and Etizolam (etizolam) Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), NATEGLINIDE (View Nateglinide Review and Nateglinide Label ), MESALAMINE (View Mesalamine Review and Mesalamine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), TRIMEBUTINE MALEATE (TRIMEBUTINE MALEATE) (View Trimebutine Maleate (trimebutine Maleate) Review and Trimebutine Maleate (trimebutine Maleate) Label ). Patient was hospitalized.

5409405-3 | Swollen Tongue
on Jul 27, 2007 Female patient from JAPAN , 25 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). After Pentasa was administered, patient had the following side effects: swollen tongue. Pentasa dosage: See Image.

5409402-8 | Cardiac Failure, Cardiac Valve Disease, Myocarditis
Patient was taking Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, cardiac valve disease, myocarditis on Jul 23, 2007 from JAPAN Additional patient health information: Male patient , 79 years of age, was diagnosed with colitis ulcerative and. Pentasa dosage: 250 Mg, 3x/day:tid, Oral.

5398781-6 | Cardiac Failure, Cardiac Valve Disease, Myocarditis
Adverse event was reported on Jul 12, 2007 by a Male patient taking Pentasa (View Usage) (Dosage: 250 Mg, 3x/day:tid, Oral) was diagnosed with colitis ulcerative and. Location: DENMARK , 79 years of age, Patient had the following side effects: cardiac failure, cardiac valve disease, myocarditis.

5398780-4 | Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Condition Aggravated, Disease Recurrence, Interstitial Lung Disease, Pneumonia Cytomegaloviral, Pyrexia, Rash, White Blood Cell Count Increased
on Jul 12, 2007 Male patient from DENMARK , 63 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). After Pentasa was administered, patient had the following side effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased, condition aggravated, disease recurrence, interstitial lung disease, pneumonia cytomegaloviral, pyrexia, rash (What is rash?), white blood cell count increased. Pentasa dosage: 1000 Mg, 3x/day:tid, Oral; 250 Mg, 1x/day; Qd, Oral. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

5398779-8 | Eosinophilic Pneumonia
on Jul 12, 2007 Female patient from DENMARK , 16 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: eosinophilic pneumonia. Pentasa dosage: 500 Mg, 3x/day:tid, Oral. Patient was hospitalized.

5398343-0 | Condition Aggravated, Crohn's Disease, Paraesthesia
Patient was taking Pentasa (View Usage). Patient had the following side effects: condition aggravated, crohn's disease (What is crohn's disease?), paraesthesia on Jul 16, 2007 from UNITED STATES Additional patient health information: Female patient , 61 years of age, weighting 134.9 lb, was diagnosed with crohn's disease (What is crohn's disease?) and. Pentasa dosage: 250 Mg, 4x/day;qid, Oral. During the same period patient was treated with FLAGYL (Intravenous) (View Flagyl Review and Flagyl Label ). Patient was hospitalized.

5393037-X | Eosinophilic Pneumonia, Gastroenteritis
Adverse event was reported on Jul 06, 2007 by a Male patient taking Pentasa (View Usage) (Dosage: 750 Mg, 3x/day; Tid, Oral) was diagnosed with colitis ulcerative and. Location: DENMARK , 56 years of age, After Pentasa was administered, patient had the following side effects: eosinophilic pneumonia, gastroenteritis (What is gastroenteritis?). During the same period patient was treated with BUSCOPAN /00008702/ (HYOSCINE BUTYLBROMIDE) (View Buscopan /00008702/ (hyoscine Butylbromide) Review and Buscopan /00008702/ (hyoscine Butylbromide) Label ).

5393036-8 | Neutropenia
on Jul 06, 2007 Male patient from DENMARK , 38 years of age, was diagnosed with crohn's disease (What is crohn's disease?), anaemia, abdominal discomfort and was treated with Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia. Pentasa dosage: 4 G Daily, Oral. During the same period patient was treated with FERROUS SULFATE TAB (600 Mg Daily, Oral) (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), OMEPRAZOLE (40 Mg Dialy, Oral) (View Omeprazole Review and Omeprazole Label ), PREDNISOLONE (Oral) (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized and became disabled.

5390021-7 | Arthralgia, Back Pain, Colitis Ulcerative, Condition Aggravated, Pain In Jaw, Pyrexia
on Jun 29, 2007 Male patient from JAPAN , 52 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). Patient had the following side effects: arthralgia, back pain (What is back pain?), colitis ulcerative, condition aggravated, pain in jaw, pyrexia. Pentasa dosage: 500 Mg, 3x/ Day:tid, Oral, 750 Mg, 1x/day; Qd, Oral. During the same period patient was treated with TIQUIZIUM BROMIDE (View Tiquizium Bromide Review and Tiquizium Bromide Label ). Patient was hospitalized.

5389881-5 | Interstitial Lung Disease
Patient was taking Pentasa (View Usage). After Pentasa was administered, patient had the following side effects: interstitial lung disease on Jun 27, 2007 from DENMARK Additional patient health information: Male patient , 63 years of age, was diagnosed with colitis ulcerative and. Pentasa dosage: 1000 Mg, 3x/day:tid, Oral. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

5386010-9 | Neutropenia
Adverse event was reported on Jun 26, 2007 by a Male patient taking Pentasa (View Usage) (Dosage: 4 G Daily, Oral) was diagnosed with crohn's disease (What is crohn's disease?), anaemia, abdominal discomfort and. Location: DENMARK , 38 years of age, Patient experienced the following unwanted or unexpected effects: neutropenia. During the same period patient was treated with FERROUS SULFATE TAB (600 Mg Daily, Oral) (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), OMEPRAZOLE (40 Mg Daily, Oral) (View Omeprazole Review and Omeprazole Label ), PREDNISOLONE (Unk, Unk, Oral) (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized and became disabled.

5383499-6 | Gastric Ulcer, Gastroduodenitis
on Jun 21, 2007 Female patient from DENMARK , 46 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). Patient had the following side effects: gastric ulcer, gastroduodenitis. Pentasa dosage: 3 G Daily, Oral. During the same period patient was treated with PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), KETOROLAC TROMETHAMINE (View Ketorolac Tromethamine Review and Ketorolac Tromethamine Label ), RANIDIL (RANITIDINE HYDROCHLORIDE) (View Ranidil (ranitidine Hydrochloride) Review and Ranidil (ranitidine Hydrochloride) Label ). Patient was hospitalized.

5382862-7 | Limb Reduction Defect, Pregnancy
on Jul 03, 2007 Female patient from UNITED STATES , 29 years of age, weighting 125.0 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Pentasa (View Usage). After Pentasa was administered, patient had the following side effects: limb reduction defect, pregnancy (What is pregnancy?). Pentasa dosage: 2 Gms Bid Po.

5381293-3 | Rectal Haemorrhage
Patient was taking Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: rectal haemorrhage on Jul 11, 2006 from DENMARK Additional patient health information: Female patient , 16 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and. Pentasa dosage: 4 G Daily, Oral ; 2 G Daily, Oral. Patient was hospitalized.

5381292-1 | Arthralgia, Hyperhidrosis, Paraesthesia
Adverse event was reported on May 22, 2006 by a Female patient taking Pentasa (View Usage) (Dosage: 4 G Daily, Oral) was diagnosed with proctitis ulcerative and. Location: DENMARK , 45 years of age, Patient had the following side effects: arthralgia, hyperhidrosis, paraesthesia. During the same period patient was treated with IMIPRAMINE (View Imipramine Review and Imipramine Label ).

5381291-X | Abdominal Pain, Diarrhoea, Pyrexia, Vomiting
on May 18, 2006 Female patient from DENMARK , child 8 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). After Pentasa was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), diarrhoea, pyrexia, vomiting. Pentasa dosage: 500 Mg, 2x/day:bid, Oral ; 500 Mg, 3x/day:tid, Oral. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

5381290-8 | Nausea
on Jun 06, 2006 Female patient from DENMARK , 76 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?). Pentasa dosage: . During the same period patient was treated with SULFASALAZIN (SULFASALAZINE) (View Sulfasalazin (sulfasalazine) Review and Sulfasalazin (sulfasalazine) Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ). Patient was hospitalized.

5381288-X | Hepatic Function Abnormal, Pyrexia
Patient was taking Pentasa (View Usage). Patient had the following side effects: hepatic function abnormal, pyrexia on Jun 07, 2006 from DENMARK Additional patient health information: Male patient , 75 years of age, was diagnosed with colitis ulcerative and. Pentasa dosage: 750 Mg, 3x/day:tid, Oral. Patient was hospitalized.

5381287-8 | Abdominal Pain, Diarrhoea, Haematochezia
Adverse event was reported on Jun 30, 2006 by a Female patient taking Pentasa (View Usage) (Dosage: 22250 Mg Daily, Oral) was diagnosed with inflammatory bowel disease and. Location: DENMARK , 72 years of age, After Pentasa was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), diarrhoea, haematochezia. During the same period patient was treated with PYRIDOXAL PHOSPHATE (PYRIDOXAL PHOSPHATE) (View Pyridoxal Phosphate (pyridoxal Phosphate) Review and Pyridoxal Phosphate (pyridoxal Phosphate) Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), PROPYLTHIOURACIL (View Propylthiouracil Review and Propylthiouracil Label ). Patient was hospitalized.

5381286-6 | Nephritis Interstitial
on Jul 27, 2006 Male patient from DENMARK , 17 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: nephritis interstitial. Pentasa dosage: 500 Mg, 3x/day;tid, Oral ; 250 Mg, 3x/day:tid, Oral ; 500 Mg, 3x/day:tid, Oral.

5381285-4 | Haematochezia
on Apr 06, 2007 Male patient from JAPAN , 57 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). Patient had the following side effects: haematochezia. Pentasa dosage: 1 G Daily, Rectal. During the same period patient was treated with BETAMETHASONE (View Betamethasone Review and Betamethasone Label ). Patient was hospitalized.

5381284-2 | Haemoglobin Decreased, White Blood Cell Count Decreased
Patient was taking Pentasa (View Usage). After Pentasa was administered, patient had the following side effects: haemoglobin decreased, white blood cell count decreased on May 10, 2007 from UNITED STATES Additional patient health information: Male patient , 48 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and. Pentasa dosage: 1000 Mg 3x's Daily, Oral. During the same period patient was treated with MERCAPTOPURINE (100 Mg Daily) (View Mercaptopurine Review and Mercaptopurine Label ), QUESTRAN (View Questran Review and Questran Label ).

5381283-0 | Nephritis Interstitial, Pericarditis
Adverse event was reported on Apr 20, 2007 by a Female patient taking Pentasa (View Usage) (Dosage: 500 Mg 3x's Daily, Oral) was diagnosed with colitis ulcerative and. Location: JAPAN , child 12 years of age, Patient experienced the following unwanted or unexpected effects: nephritis interstitial, pericarditis. During the same period patient was treated with CEFMETAZOLE (CEFMETAZOLE) (View Cefmetazole (cefmetazole) Review and Cefmetazole (cefmetazole) Label ), GENTAMICIN SULFATE (View Gentamicin Sulfate Review and Gentamicin Sulfate Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), MINOCYCLINE HYDROCHLORIDE (View Minocycline Hydrochloride Review and Minocycline Hydrochloride Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), PREDNISOLONE SODIUM SUCCINATE INJ (View Prednisolone Sodium Succinate Inj Review and Prednisolone Sodium Succinate Inj Label ), PENTAZOCINE LACTATE (View Pentazocine Lactate Review and Pentazocine Lactate Label ), TEPRENONE (TEPRENONE) (View Teprenone (teprenone) Review and Teprenone (teprenone) Label ).

5381282-9 | Blood Amylase Increased, Pancreatitis
on Mar 21, 2007 Male patient from FRANCE , 13 years of age, was diagnosed with acute leukaemia and was treated with Pentasa (View Usage). Patient had the following side effects: blood amylase increased, pancreatitis. Pentasa dosage: 1500 Mg Daily, Oral. During the same period patient was treated with FOSCAVIR (3.5 Mg Daily, Intravenous) (View Foscavir Review and Foscavir Label ), SOLU MEDROL (40 Mg Daily, Intravenous) (View Solu-medrol Review and Solu-medrol Label ), GLEEVEC (400 Mg Daily, Oral) (View Gleevec Review and Gleevec Label ), MOPRAL (OMEPRAZOLE) (40 Mg Daily, Oral) (View Mopral (omeprazole) Review and Mopral (omeprazole) Label ), ALIZAPRIDE HYDROCHLORIDE (ALIZAPRIDE HYDROCHLORIDE (View Alizapride Hydrochloride (alizapride Hydrochloride Review and Alizapride Hydrochloride (alizapride Hydrochloride Label ), ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ), IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ), NALBUPHINE (View Nalbuphine Review and Nalbuphine Label ). Patient was hospitalized.

5381281-7 | Colitis Ulcerative
on Apr 09, 2007 Male patient from JAPAN , 13 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). After Pentasa was administered, patient had the following side effects: colitis ulcerative. Pentasa dosage: 1500 Mg Daily, Oral; 2250 Mg Daily. Patient was hospitalized.

5381280-5 | Anaemia, Blood Creatinine Increased, Blood Pressure Increased, Nephritis Interstitial
Patient was taking Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, blood creatinine increased, blood pressure increased, nephritis interstitial on Apr 30, 2007 from UNITED STATES Additional patient health information: Female patient , 40 years of age, weighting 192.0 lb, was diagnosed with colitis ulcerative and. Pentasa dosage: 500 Mg 3xs Daily, Oral. During the same period patient was treated with ASACOL (1 Tab 4xs Daily, Oral) (View Asacol Review and Asacol Label ), MULTIVITAMIN (View Multivitamin Review and Multivitamin Label ).

5381279-9 | Lipase Increased, Neutrophil Count Decreased, Pancreatitis
Adverse event was reported on Mar 28, 2007 by a Male patient taking Pentasa (View Usage) (Dosage: 4 G, Daily, Oral; 2 G Daily) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: FRANCE , 55 years of age, Patient had the following side effects: lipase increased, neutrophil count decreased, pancreatitis. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

5381278-7 | Aplasia Pure Red Cell
on Mar 16, 2007 Female patient from JAPAN , 21 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Pentasa (View Usage). After Pentasa was administered, patient had the following side effects: aplasia pure red cell. Pentasa dosage: 750 Mg 3x's Daily, Oral. Patient was hospitalized.

5381277-5 | Pericarditis
on Feb 14, 2007 Male patient from FRANCE , 15 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: pericarditis. Pentasa dosage: 3 G Daily, Oral. During the same period patient was treated with METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), CACIT D3 (CALCIUM CARBONATE, COLECALCIFEROL) (View Cacit D3 (calcium Carbonate, Colecalciferol) Review and Cacit D3 (calcium Carbonate, Colecalciferol) Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), PREDNISOLONE SODIUM SULFOBENZOATE (View Prednisolone Sodium Sulfobenzoate Review and Prednisolone Sodium Sulfobenzoate Label ). Patient was hospitalized.

5381276-3 | Liver Disorder
Patient was taking Pentasa (View Usage). Patient had the following side effects: liver disorder on Mar 26, 2007 from JAPAN Additional patient health information: Male patient , 39 years of age, was diagnosed with colitis ulcerative and. Pentasa dosage: Oral; 500 Mg 3x's Daily; 250 3x's Daily; 250 M X2.500mg X1; 1250 Mg Daily; 1500 Mg Daily; 2000 Mg Da. During the same period patient was treated with PREDNISOLONE (30 Mg Daily, Oral; 20 Mg Daily; 15 Mg Daily) (View Prednisolone Review and Prednisolone Label ).